molecular aspects of TLR4 activation
natural TLR4 modulators
TLR4-based therapeutics
chronic inflammations
animal models of TLR4
chronic pathologies
field of chemical biology
asthma
short-term scientific objective
long-term scientific objective
integrated chemical-biology approach
emerging molecular target
specific pharmacological treatment
efficient pharmacological treatment
anti-inflammatory agents
broad competences
CNS diseases
autoimmune disorders
molecular mechanisms of innate immunity
young researchers
natural compounds
training programme
private sector
non-academic sector
broad spectrum of modern day disorders
anti-sepsis agents
Early Stage Researchers
company management skills
inter-disciplinary research
inter-cultural mindset
allergies
biochemistry
biophysics
novel
information
pharmacology expertise
synergies
TOLLerant project
unique combination of chemistry
ESRs
experience
function
antagonists
new generation of innovative
vaccine adjuvants
therapeutic potential
CD14
entrepreneurship
nanoparticles
Receptor
senior scientists
allergy
COST action BM1003
international team
consolidated group interactions
TRL4 recognition system
employability
cancer
MD
components
start-up companies